Directory
>
Peter Chin
Peter Chin
Sr. Vice President & Head of Late-Stage Clinical Development and Medical Affairs | Denali Therapeutics
South San Francisco, California, United States
Peter Chin
Summary
Peter Chin is a seasoned executive in the biopharmaceutical industry, currently serving as the Senior Vice President at Denali Therapeutics. With a robust background in clinical development and medical affairs, he has dedicated over two decades to advancing therapies in neurology and other critical therapeutic areas. His expertise spans immunology, oncology, and regulatory submissions, making him a pivotal figure in drug development. Peter's leadership experience is underscored by his roles at major companies like Genentech and Novartis, where he has directed late-stage clinical programs. He holds a Doctor of Medicine from Dartmouth Medical School and a Master of Science in Health Services from UCLA. Peter's commitment to improving patient outcomes is evident in his extensive work in clinical trials and pharmacovigilance. He is also known for fostering innovation in clinical practices, ensuring adherence to good clinical practices (GCP). Outside of his professional life, Peter is passionate about mentoring the next generation of medical professionals and contributing to advancements in healthcare policy.
Peter Chin
Work Experience
Sr. Vice President & Head of Late-Stage Clinical Development and Medical Affairs at
Denali Therapeutics
October 2021 - Present
Vice President & Head of Late-Stage Clinical Development and Medical Affairs at
Denali Therapeutics
April 2019 - October 2021
Group Medical Director for Neuroscience | U.S. Medical Affairs at
Genentech Foundation
August 2016 - March 2019
Principal Medical Director | Roche Global Product Development - Neuroscience at
Roche Global Neuroscience Development
August 2014 - July 2016
Global Program Medical Director, Executive Director at
Novartis
March 2011 - July 2014
Medical Director | Roche Global Product Development - Neuroscience at
Genentech Foundation
July 2009 - February 2011
Associate Medical Director | Immunology, Tissue Growth and Repair Development at
Genentech Itgr Development
September 2007 - June 2009
Sr. Health Economist | Health Economics and Outcomes Research at
Genentech Health Economics And Outcomes Research
July 2005 - August 2007
Robert Wood Johnson Clinical Scholar at
Ucla
July 2003 - June 2005
Resident Physician, Neurology at
University of Washington, LLC
July 1999 - June 2003
Research Associate at
Gladstone Institutes
September 1992 - July 1994
Peter Chin
Education
Dartmouth Medical School, Doctor Of Medicine (Md)
University of California, Berkeley, Bachelor Of Arts (B.A.)
University of California, Los Angeles, Master Of Science - Ms
Frequently Asked Questions about Peter Chin
What is Peter Chin email address?
Peter Chin's primary email address is **********@denalitherapeutics.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Peter Chin work for?
Peter Chin is a Sr. Vice President & Head of Late-Stage Clinical Development and Medical Affairs at Denali Therapeutics, a company specializing in Commercial physical research.
Where Peter Chin graduated from?
Peter Chin holds a degree in from Dartmouth Medical School.
How can I directly contact Peter Chin?
To contact Peter Chin directly, you can use the email address **********@denalitherapeutics.com. Complete contact information is available upon registration with Muraena.
Who is Peter Chin?
Peter Chin is a seasoned executive in the biopharmaceutical industry, currently serving as the Senior Vice President at Denali Therapeutics. With a robust background in clinical development and medical affairs, he has dedicated over two decades to advancing therapies in neurology and other critical therapeutic areas. His expertise spans immunology, oncology, and regulatory submissions, making him a pivotal figure in drug development. Peter's leadership experience is underscored by his roles at major companies like Genentech and Novartis, where he has directed late-stage clinical programs. He holds a Doctor of Medicine from Dartmouth Medical School and a Master of Science in Health Services from UCLA. Peter's commitment to improving patient outcomes is evident in his extensive work in clinical trials and pharmacovigilance. He is also known for fostering innovation in clinical practices, ensuring adherence to good clinical practices (GCP). Outside of his professional life, Peter is passionate about mentoring the next generation of medical professionals and contributing to advancements in healthcare policy.
Peter`s contact details
**********@denalitherapeutics.com
**********@gene.com
Colleagues
CEO
VP, US ETV Franchise and Global Product Strategy
Director Board Of Directors
Executive Director, Legal Department
Vice President, Technical Operations
Executive Director
Vice President of Investor Relations
Executive Director, Corporate Development
Vice President, Clinical Manufacturing
Board Member